Galpha Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 30-11-2024
- Paid Up Capital ₹ 4.99 Cr
as on 30-11-2024
- Company Age 38 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 26.97 Cr
as on 30-11-2024
- Satisfied Charges ₹ 119.57 Cr
as on 30-11-2024
- Revenue 7.79%
(FY 2024)
- Profit 10.22%
(FY 2024)
- Ebitda 21.37%
(FY 2024)
- Net Worth -230.16%
(FY 2024)
- Total Assets -27.55%
(FY 2024)
About Galpha Laboratories
The Corporate was formerly known as Galpha Laboratories Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.99 Cr.
The company currently has active open charges totaling ₹26.97 Cr. The company has closed loans amounting to ₹119.57 Cr, as per Ministry of Corporate Affairs (MCA) records.
Nawal Singh, Jyoti Singh, Anju Singh, and Five other members serve as directors at the Company.
- CIN/LLPIN
U24230BR1986PLC002323
- Company No.
002323
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
14 Apr 1986
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Galpha Laboratories?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nawal Singh | Managing Director | 10-Mar-2015 | Current |
Board Members(7)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Kumar Saurabh | Director | 22-Mar-2016 | Current |
Rinu Sharma | Director | 01-Jun-2002 | Current |
Jyoti Singh | Director | 01-Jun-2002 | Current |
Anju Singh | Director | 15-Jun-2001 | Current |
Anand Singh | Director | 01-Apr-2015 | Current |
Neha Singh | Director | 27-Sep-2010 | Current |
Financial Performance and Corporate Structure Insights of Galpha Laboratories.
Galpha Laboratories Limited., for the financial year ended 2024, experienced modest growth in revenue, with a 7.79% increase. The company also saw a substantial improvement in profitability, with a 10.22% increase in profit. The company's net worth observed a substantial decline by a decrease of 230.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Galpha Laboratories?
In 2024, Galpha Laboratories had a promoter holding of 59.84% and a public holding of 40.16%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 30 May 2018 | ₹25.00 Cr | Open |
Union Bank Of India Creation Date: 22 Nov 2013 | ₹5.00 M | Open |
Citi Bank N.A. Creation Date: 24 Oct 2013 | ₹1.47 Cr | Open |
How Many Employees Work at Galpha Laboratories?
Galpha Laboratories has a workforce of 952 employees as of Nov 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Galpha Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Galpha Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.